Tech Company Inital Public Offerings
BioAtla IPO
BioAtla, operating out of San Diego, debuted as a public company on 12/15/2020.
Transaction Overview
Company Name
Announced On
12/15/2020
Transaction Type
IPO
Amount
$189,000,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:approximately $40.0 million to $60.0 million to fund the clinical development of BA3011 for the treatment of soft tissue and bone sarcoma patients through a Phase 2 clinical trial and for the treatment of NSCLC patients through a Phase 2 clinical trial;approximately $40.0 million to $60.0 million to fund the clinical development of BA3021 for the treatment of NSCLC and for the treatment of melanoma, each through a Phase 2 clinical trial;approximately $20.0 million to $30.0 million to fund IND-enabling studies and initial Phase 1 clinical supply of our first two CAB bispecific candidates;approximately $5.0 million to $10.0 million to fund our ongoing efforts to develop additional clinical product candidates from our CAB platform; andthe remaining proceeds for working capital and other general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
11085 Torreyana Rd.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
BioAtla (Nasdaq: BCAB) is a San Diego biotech company that develops novel monoclonal antibody and cell based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO) platforms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Short
Chief Financial Officer
Richard Waldron
Chief Scientific Officer
Gerhard Frey
Co-Founder
Carolyn Short
Vice President
William Boyle
Vice President
Philippe Martin
Vice President
Monica Sullivan
VP - Bus. Development
Michael Melnick
VP - Human Resources
Susie Melody
VP - R & D
Cathy Chang
Browse more venture capital transactions:
Prev: 12/15/2020: Arya.ag venture capital transaction
Next: 12/15/2020: GoFor Industries venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs